Non-Functional Pancreatic Neuroendocrine Tumor
1 clinical trials · Condition
◉ Watch Non-Functional Pancreatic Neuroendocrine Tumor
| Record | Firm | Date |
|---|---|---|
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
Track Non-Functional Pancreatic Neuroendocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.